ArticleCureus2026
Cytomegalovirus Infection in an Extremely Preterm Infant: A Diagnostic Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytomegalovirus (CMV) infection in the extremely preterm infant represents a major diagnostic challenge: its clinical manifestations overlap with comorbidities inherent to prematurity, underlying immunodeficiency may suppress viral replication below detectable thresholds, and the diagnostic window for confirming congenital infection closes irreversibly at 21 days of life. An extremely preterm female infant (26 weeks, 800 g) had a neonatal course complicated by bronchopulmonary dysplasia, leukoencephalopathy, and chorioretinitis - findings that, individually, were attributable to prematurity. CMV was not tested within the 21-day diagnostic window. A plasma CMV PCR at day 44, triggered by clinical deterioration, returned negative. At 70 days of life, severe multilobar pneumonia with respiratory failure requiring high-frequency oscillatory ventilation developed without an identifiable bacterial aetiology. Targeted bronchoalveolar lavage confirmed CMV at 136,000 IU/mL, markedly dissociated from simultaneous plasma viraemia of 9,910 IU/mL. Primary combined immunodeficiency (T⁻/B⁺/NK⁺ pattern) was diagnosed simultaneously. Ganciclovir therapy achieved progressive viral load reduction. In the extremely preterm infant, CMV may remain clinically invisible behind more immediate diagnoses. A negative plasma CMV PCR does not exclude active infection in the setting of combined immunodeficiency. Severe multisystem deterioration without an identified aetiology should prompt site-directed CMV investigation and simultaneous immunological evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.